{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:26:46Z","timestamp":1780590406855,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-025-00710-2","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T15:02:18Z","timestamp":1741964538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Factors associated with thrombosis among solid organ cancer patients in Kuala Lumpur, Malaysia"],"prefix":"10.1186","volume":"23","author":[{"given":"Lailatulema","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibtisam","family":"Muhamad Nor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuad","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivakumar","family":"Palaniappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang Yong","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharifa Ezat","family":"Wan Puteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Afiqah","family":"Muhamad Jamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor Rafeah","family":"Tumian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"710_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.trsl.2020.06.012","volume":"225","author":"AS Kim","year":"2020","unstructured":"Kim AS, Khorana AA, McCrae KR. Mechanisms and biomarkers of cancer-associated thrombosis. Translational Res. 2020;225:33\u201353.","journal-title":"Translational Res"},{"key":"710_CR2","doi-asserted-by":"crossref","unstructured":"Zhao H, Liang F, Ling Y, Li T, Fang B, Deng T et al. Prevalence and treatment of venous thromboembolism in patients with solid tumors. Exp Ther Med. 2022;24(6).","DOI":"10.3892\/etm.2022.11679"},{"key":"710_CR3","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.2147\/IJGM.S320492","volume":"14","author":"M Mosaad","year":"2021","unstructured":"Mosaad M, Elnaem MH, Cheema E, Ibrahim I, Ab Rahman J, Kori AN, et al. Cancer-Associated thrombosis: A clinical scoping review of the risk assessment models across solid tumours and haematological malignancies. Int J Gen Med. 2021;14:3881.","journal-title":"Int J Gen Med"},{"issue":"6","key":"710_CR4","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","volume":"49","author":"AJ Walker","year":"2013","unstructured":"Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer-A cohort study using linked united Kingdom databases. Eur J Cancer. 2013;49(6):1404\u201313.","journal-title":"Eur J Cancer"},{"key":"710_CR5","doi-asserted-by":"crossref","unstructured":"Yu Y, Bin, Gau JP, Liu CY, Yang MH, Chiang SC, Hsu HC et al. A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system. Thromb Haemost. 2012;108(2).","DOI":"10.1160\/TH12-01-0010"},{"key":"710_CR6","doi-asserted-by":"crossref","unstructured":"K\u00f6nigsbr\u00fcgge O, Pabinger I, Ay C. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and thrombosis study (CATS). Thromb Res. 2014;133 Suppl 2(SUPPL. 2).","DOI":"10.1016\/S0049-3848(14)50007-2"},{"issue":"11","key":"710_CR7","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/jjco\/hyaa112","volume":"50","author":"Y Ohashi","year":"2021","unstructured":"Ohashi Y, Ikeda M, Kunitoh H, Sasako M, Okusaka T, Mukai H, et al. Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE registry. Jpn J Clin Oncol. 2021;50(11):1246\u201353.","journal-title":"Jpn J Clin Oncol"},{"issue":"8","key":"710_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1055\/s-0041-1733927","volume":"47","author":"M Franchini","year":"2021","unstructured":"Franchini M, Tufano A, Casoria A, Coppola A. Arterial thrombosis in Cancer patients: an update. Semin Thromb Hemost. 2021;47(8):942\u20139.","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"710_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1055\/s-0040-1718926","volume":"47","author":"J Costa","year":"2021","unstructured":"Costa J, Ara\u00fajo A. Cancer-Related venous thromboembolism: from pathogenesis to risk assessment. Semin Thromb Hemost. 2021;47(6):669\u201376.","journal-title":"Semin Thromb Hemost"},{"issue":"20","key":"710_CR10","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1002\/cncr.34937","volume":"129","author":"H Bolek","year":"2023","unstructured":"Bolek H, \u00dcr\u00fcn Y. Cancer-associated thrombosis and drug\u2013drug interactions of antithrombotic and antineoplastic agents. Cancer. 2023;129(20):3216\u201329.","journal-title":"Cancer"},{"issue":"Supplement 1","key":"710_CR11","doi-asserted-by":"publisher","first-page":"5660","DOI":"10.1182\/blood-2022-157218","volume":"140","author":"C Jones","year":"2022","unstructured":"Jones C, Menchaca K, Ostos C, Durbin J, Chen K, Peles S. Outcomes of thromboembolism in COVID-19 Cancer patients vs Non-Cancer patients. Blood. 2022;140(Supplement 1):5660.","journal-title":"Blood"},{"key":"710_CR12","doi-asserted-by":"crossref","unstructured":"Didier AJ, Campbell A, Nandwani S, Fahoury A, Arsene C. In-hospital mortality patterns and risk factors in patients with cancer with COVID-19. 42(16_suppl):e23070-e23070.","DOI":"10.1200\/JCO.2024.42.16_suppl.e23070"},{"key":"710_CR13","doi-asserted-by":"crossref","unstructured":"Khorana A, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902\u20137","DOI":"10.1182\/blood-2007-10-116327"},{"issue":"6","key":"710_CR14","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3324\/haematol.2018.209114","volume":"104","author":"FI Mulder","year":"2019","unstructured":"Mulder FI, Candeloro M, Kamphuisen PW, Di Nisio M, Bossuyt PM, Guman N, et al. The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis. Haematologica. 2019;104(6):1277\u201387.","journal-title":"Haematologica"},{"key":"710_CR15","doi-asserted-by":"crossref","unstructured":"Verso M, Agnelli G, Barni S, Gasparini G, LaBianca R. A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the protecht score. Intern Emerg Med. 2012:291\u20132.","DOI":"10.1007\/s11739-012-0784-y"},{"issue":"41","key":"710_CR16","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1055\/s-0033-1349608","volume":"138","author":"U Pelzer","year":"2013","unstructured":"Pelzer U, Sinn M, Stieler J, Riess H. [Primary Pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?]. Dtsch Med Wochenschr. 2013;138(41):2084\u20138.","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"710_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-022-01289-1","volume":"15","author":"C Frere","year":"2022","unstructured":"Frere C, Farge D, Schrag D, Prata PH, Connors JM. Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials. J Hematol Oncol. 2022;15(1):1\u20136.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"710_CR18","doi-asserted-by":"publisher","first-page":"e2325283","DOI":"10.1001\/jamanetworkopen.2023.25283","volume":"6","author":"I Riaz","year":"2023","unstructured":"Riaz I, Bin, Fuentes H, Deng Y, Naqvi SAA, Yao X, Sangaralingham LR, et al. Comparative effectiveness of anticoagulants in patients with Cancer-Associated thrombosis. JAMA Netw Open. 2023;6(7):e2325283.","journal-title":"JAMA Netw Open"},{"issue":"22","key":"710_CR19","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2023.7843","volume":"329","author":"D Schrag","year":"2023","unstructured":"Schrag D, Uno H, Rosovsky R, Rutherford C, Sanfilippo K, Villano JL, et al. Direct oral anticoagulants vs Low-Molecular-Weight heparin and recurrent VTE in patients with cancer: A randomized clinical trial. JAMA. 2023;329(22):1924\u201333.","journal-title":"JAMA"},{"issue":"9","key":"710_CR20","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/jth.14219","volume":"16","author":"AA Khorana","year":"2018","unstructured":"Khorana AA, Noble S, Lee AYY, Soff G, Meyer G, O\u2019Connell C, et al. Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH. J Thromb Haemost. 2018;16(9):1891\u20134.","journal-title":"J Thromb Haemost"},{"issue":"9","key":"710_CR21","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1111\/jth.13761","volume":"15","author":"F Dentali","year":"2017","unstructured":"Dentali F, Pegoraro S, Barco S, di Minno MND, Mastroiacovo D, Pomero F, et al. Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study. J Thromb Haemost. 2017;15(9):1757\u201363.","journal-title":"J Thromb Haemost"},{"key":"710_CR22","unstructured":"CPG. \u2018Management of Obesity\u2019 - Malaysia Endocrine & Metabolic Society. [cited 2025 Feb 11]. Available from: https:\/\/mems.my\/cpg-management-of-obesity\/"},{"key":"710_CR23","doi-asserted-by":"publisher","first-page":"669288","DOI":"10.3389\/fcvm.2021.669288","volume":"8","author":"LH Lee","year":"2021","unstructured":"Lee LH, Nagarajan C, Tan CW, Ng HJ. Epidemiology of Cancer-Associated thrombosis in Asia: A systematic review. Front Cardiovasc Med. 2021;8:669288.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"710_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11239-020-02180-x","volume":"50","author":"JI Weitz","year":"2020","unstructured":"Weitz JI, Haas S, Ageno W, Goldhaber SZ, Turpie AGG, Goto S, et al. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE. J Thromb Thrombolysis. 2020;50(2):267\u201377.","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"710_CR25","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jth.15599","volume":"20","author":"F Moik","year":"2022","unstructured":"Moik F, Colling M, Mah\u00e9 I, Jara-Palomares L, Pabinger I, Ay C. Extended anticoagulation treatment for cancer-associated thrombosis-Rates of recurrence and bleeding beyond 6 months: A systematic review. J Thromb Haemost. 2022;20(3):619\u201334.","journal-title":"J Thromb Haemost"},{"issue":"11","key":"710_CR26","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1111\/cas.15527","volume":"113","author":"M Ikeda","year":"2022","unstructured":"Ikeda M, Uetake H, Yoshino T, Hata T, Oba MS, Takita A, et al. Incidence and risk factors for venous thromboembolism, bleeding, and death in colorectal cancer (Cancer-VTE Registry). Cancer Sci. 2022;113(11):3901\u201311.","journal-title":"Cancer Sci"},{"issue":"3","key":"710_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/hon.785","volume":"24","author":"PC Winter","year":"2006","unstructured":"Winter PC. The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology. Hematol Oncol. 2006;24(3):126\u201333.","journal-title":"Hematol Oncol"},{"key":"710_CR28","doi-asserted-by":"crossref","unstructured":"Tuzovic M, Herrmann J, Iliescu C, Marmagkiolis K, Ziaeian B, Yang EH. Arterial thrombosis in patients with Cancer. Curr Treat Options Cardiovasc Med. 2018;20(5).","DOI":"10.1007\/s11936-018-0635-x"},{"issue":"1","key":"710_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1538-7836.2009.03680.x","volume":"8","author":"R Simanek","year":"2010","unstructured":"Simanek R, Vormittag R, Ay C, Alguel G, Dunkler D, Schwarzinger I, et al. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and thrombosis study (CATS). J Thromb Haemost. 2010;8(1):114\u201320.","journal-title":"J Thromb Haemost"},{"key":"710_CR30","doi-asserted-by":"crossref","unstructured":"Chong CT, Lai WK, Sallehuddin SM, Ganapathy SS. Prevalence of overweight and its associated factors among Malaysian adults: findings from a nationally representative survey. PLoS ONE. 2023;18(8).","DOI":"10.1371\/journal.pone.0283270"},{"key":"710_CR31","doi-asserted-by":"crossref","unstructured":"Kwaifa IK, Bahari H, Yong YK, Md Noor S. Endothelial dysfunction in Obesity-Induced inflammation: molecular mechanisms and clinical implications. Biomolecules. 2020;10(2).","DOI":"10.3390\/biom10020291"},{"issue":"2","key":"710_CR32","first-page":"162","volume":"93","author":"C Hotoleanu","year":"2020","unstructured":"Hotoleanu C. Association between obesity and venous thromboembolism. Med Pharm Rep. 2020;93(2):162\u20138.","journal-title":"Med Pharm Rep"},{"key":"710_CR33","doi-asserted-by":"crossref","unstructured":"Peng M, Yang S, Li G, Zhang T, Qin X, Shi C, et al. Solid tumor complicated with venous thromboembolism: A 10-Year retrospective Cross-Sectional study. Clin Appl Thromb Hemost. 2021;27:1076029620975484.","DOI":"10.1177\/1076029620975484"},{"issue":"7","key":"710_CR34","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1200\/JCO.2005.04.2150","volume":"24","author":"A Alcalay","year":"2006","unstructured":"Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol. 2006;24(7):1112\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"710_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1200\/JCO.2006.07.4393","volume":"25","author":"HK Chew","year":"2007","unstructured":"Chew HK, Wun T, Harvey DJ, Zhou H, White RH. Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol. 2007;25(1):70\u20136.","journal-title":"J Clin Oncol"},{"key":"710_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.thromres.2016.01.002","volume":"139","author":"AA Ashrani","year":"2016","unstructured":"Ashrani AA, Gullerud RE, Petterson TM, Marks RS, Bailey KR, Heit JA. Risk factors for incident venous thromboembolism in active Cancer patients: A population based Case-Control study. Thromb Res. 2016;139:29.","journal-title":"Thromb Res"},{"key":"710_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.critrevonc.2017.08.003","volume":"118","author":"A Falanga","year":"2017","unstructured":"Falanga A, Russo L, Milesi V, Vignoli A. Mechanisms and risk factors of thrombosis in cancer. Crit Rev Oncol Hematol. 2017;118:79\u201383.","journal-title":"Crit Rev Oncol Hematol"},{"key":"710_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.thromres.2018.04.009","volume":"166","author":"N van Es","year":"2018","unstructured":"van Es N, Hisada Y, Di Nisio M, Cesarman G, Kleinjan A, Mah\u00e9 I, et al. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study. Thromb Res. 2018;166:54\u20139.","journal-title":"Thromb Res"},{"issue":"16suppl","key":"710_CR39","doi-asserted-by":"publisher","first-page":"e18839","DOI":"10.1200\/JCO.2023.41.16_suppl.e18839","volume":"41","author":"MB Ibrahim","year":"2023","unstructured":"Ibrahim MB, Litvin R, Noor H, Khan AH, Ishaya M, Obeidat K, et al. COVID-19 and prevalence of venous thromboembolism among cancer patients: A nationwide inpatient sample analysis. J Clin Oncol. 2023;41(16_suppl):e18839\u201318839.","journal-title":"J Clin Oncol"},{"issue":"2","key":"710_CR40","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s12094-024-03635-w","volume":"27","author":"C L\u00f3pez-Jim\u00e9nez","year":"2025","unstructured":"L\u00f3pez-Jim\u00e9nez C, Guti\u00e9rrez A, Juliao Caama\u00f1o DS, Soto Alsar J, Catoya Villa JL, Blanco Abad C, et al. Impact of COVID-19 in the incidence of venous thromboembolism (VTE) and clinical outcomes in cancer patients: a cohort study. Clin Transl Oncol. 2025;27(2):756\u201369.","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"710_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jacasi.2021.07.006","volume":"1","author":"F Akasaka-Kihara","year":"2021","unstructured":"Akasaka-Kihara F, Sueta D, Ishii M, Maki Y, Hirakawa K, Tabata N, et al. Validation of the Khorana venous thromboembolism risk score in Japanese Cancer patients. JACC Asia. 2021;1(2):259\u201370.","journal-title":"JACC Asia"},{"key":"710_CR42","doi-asserted-by":"crossref","unstructured":"Ha H, Ko YH, Kim K, Hong J, Lee GW, Jeong SH et al. Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy. Thromb J. 2023;21(1).","DOI":"10.1186\/s12959-023-00505-3"},{"issue":"35","key":"710_CR43","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1200\/JCO.2012.42.4358","volume":"30","author":"S Seng","year":"2012","unstructured":"Seng S, Liu Z, Chiu SK, Proverbs-Singh T, Sonpavde G, Choueiri TK, et al. Risk of venous thromboembolism in patients with cancer treated with cisplatin: a systematic review and meta-analysis. J Clin Oncol. 2012;30(35):4416\u201326.","journal-title":"J Clin Oncol"},{"issue":"4","key":"710_CR44","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00018-018-2954-1","volume":"76","author":"J Miku\u0142a-Pietrasik","year":"2019","unstructured":"Miku\u0142a-Pietrasik J, Witucka A, Paku\u0142a M, Uruski P, Begier-Krasi\u0144ska B, Niklas A, et al. Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells. Cell Mol Life Sci. 2019;76(4):681\u201397.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"710_CR45","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1055\/s-0042-1744365","volume":"48","author":"SE Wan Puteh","year":"2022","unstructured":"Wan Puteh SE, Ibrahim R, Yusak S, Nik Adnan NN, Ahmat ANMF. Cancer-Associated thrombosis: implications toward Health-Related quality of life. Semin Thromb Hemost. 2022;48(4):490\u20136.","journal-title":"Semin Thromb Hemost"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00710-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-025-00710-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00710-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T15:02:25Z","timestamp":1741964545000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-025-00710-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["710"],"URL":"https:\/\/doi.org\/10.1186\/s12959-025-00710-2","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of Universiti Kebangsaan Malaysia (FF-2022-099) and the Medical Research and Ethics Committee (MREC) of the Malaysian Ministry of Health (MOH) (NMRR ID-22-01438-MW4 (IIR)), and it is in accordance with the Helsinki Declaration (IV adaptation). Written informed consent was obtained from all participants. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}